Recent Investment Analysts’ Ratings Updates for Revvity (RVTY)

Several analysts have recently updated their ratings and price targets for Revvity (NYSE: RVTY):

• 11/5/2024 – Revvity had its price target raised by analysts at Raymond James from $144.00 to $146.00. They now have an “outperform” rating on the stock.
• 11/5/2024 – Revvity had its price target lowered by analysts at Sanford C. Bernstein from $150.00 to $145.00. They now have an “outperform” rating on the stock.
• 11/5/2024 – Revvity had its price target raised by analysts at Robert W. Baird from $136.00 to $138.00. They now have an “outperform” rating on the stock.
• 11/5/2024 – Revvity had its price target raised by analysts at TD Cowen from $141.00 to $144.00. They now have a “buy” rating on the stock.
• 10/17/2024 – Revvity had its price target raised by analysts at Leerink Partners from $130.00 to $135.00. They now have an “outperform” rating on the stock.
• 10/15/2024 – Revvity was upgraded by analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating. They now have a $140.00 price target on the stock, up previously from $125.00.

Revvity Stock Down 0.0 %

Shares of NYSE:RVTY traded down $0.05 during midday trading on Monday, hitting $109.47. The stock had a trading volume of 1,299,189 shares, compared to its average volume of 836,747. Revvity, Inc. has a 12 month low of $86.30 and a 12 month high of $129.50. The company has a quick ratio of 2.97, a current ratio of 3.56 and a debt-to-equity ratio of 0.40. The business’s 50-day simple moving average is $121.52 and its 200-day simple moving average is $115.44. The company has a market cap of $13.32 billion, a P/E ratio of 52.88, a PEG ratio of 2.73 and a beta of 1.05.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Monday, November 4th. The company reported $1.28 EPS for the quarter, topping analysts’ consensus estimates of $1.13 by $0.15. Revvity had a net margin of 9.34% and a return on equity of 7.42%. The firm had revenue of $684.10 million during the quarter, compared to analysts’ expectations of $679.66 million. During the same period in the previous year, the business posted $1.18 earnings per share. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, sell-side analysts forecast that Revvity, Inc. will post 4.85 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 7th. Stockholders of record on Friday, January 17th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date is Friday, January 17th. Revvity’s dividend payout ratio is currently 13.53%.

Insider Activity at Revvity

In other Revvity news, insider Tajinder S. Vohra sold 2,154 shares of Revvity stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $121.73, for a total value of $262,206.42. Following the transaction, the insider now owns 19,652 shares in the company, valued at $2,392,237.96. The trade was a 9.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of RVTY. EdgePoint Investment Group Inc. bought a new stake in shares of Revvity during the second quarter worth about $209,221,000. Jane Street Group LLC grew its holdings in shares of Revvity by 516.4% during the first quarter. Jane Street Group LLC now owns 453,343 shares of the company’s stock worth $47,601,000 after purchasing an additional 379,802 shares during the last quarter. Janus Henderson Group PLC grew its holdings in shares of Revvity by 3.9% during the first quarter. Janus Henderson Group PLC now owns 5,664,528 shares of the company’s stock worth $594,769,000 after purchasing an additional 210,100 shares during the last quarter. Southpoint Capital Advisors LP bought a new stake in shares of Revvity during the third quarter worth about $25,550,000. Finally, Magnetar Financial LLC grew its holdings in shares of Revvity by 441.3% during the first quarter. Magnetar Financial LLC now owns 136,371 shares of the company’s stock worth $14,319,000 after purchasing an additional 111,178 shares during the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.